English 
Français 
Русский 
Español 
Deutsch 
Português 
العربية 
Italiano 
Ozelle to Debut O-Cyte 1 at ADLM 2026, Bringing Speed to AI-Powered Morphology Intelligence
The upcoming global debut is set to mark a step forward in AI-powered hematology, advancing the 4th Generation of Hematology…
Read MoreNEW & INSIGHTS
The Fourth Generation of Hematology Analysis Has Begun
For more than seventy years, hematology analysis has advanced through successive technological breakthroughs. From automated cell counting to multi-parameter flow…
Read More
Ozelle Wins German Innovation Award Gold for Advancing the Fourth Generation of Hematology Analysis
Ozelle has received a Gold Award at the German Innovation Award, one of Germany’s leading innovation honors, for its EHBT-50…
Read More
How a Regional Distributor Reignited Equipment Upgrades in a Mature Veterinary Diagnostics Market
When Installed Base Becomes the Growth Challenge Across many veterinary markets today, hematology analyzers are already widely installed in clinics.…
Read More
Precision that Empowers Regeneration — How a U.S. Biotech Advances PRP Research with Ozelle
In the rapidly evolving field of regenerative therapies, precision and consistency are everything. For a leading U.S. medical device company…
Read More
From Morphology to Clinical Insights: Ozelle’s AI-Powered Diagnostics at WHX Labs Dubai 2026
As WHX Labs Dubai 2026 opens today, visitors to Booth S1.D58 are invited to see how Ozelle transforms diagnostic testing…
Read More
The Logic Behind Innovation: How Ozelle Is Reshaping Diagnostics with AI + CBM
The Starting Point — From Traditional CBC Analyzer to Intelligent Blood Diagnostics For decades, the Complete Blood Count (CBC) has…
Read More
How to Plan Laboratory and Analytical Supplies for AI Mini‑Lab Analyzers
Why supply planning now matters as much as analyzer selection For many years, laboratory managers focused first on choosing analyzers…
Read More
Ozelle to Showcase AI‑Powered Hematology Analyzers at Expomed Eurasia 2026
Across the Middle East and Eurasia, diagnostics is entering a decisive new phase — driven by rising testing demand, chronic…
Read More